{"filings":[{"id":98572,"accession_number":"0000730464-26-000021","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Covista Q3 revenue up 4.5%, enrollment over 100k; raises FY2026 revenue and EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $487M (+4.5% YoY); adjusted EPS $1.98 vs $1.92; GAAP EPS $1.20 vs $1.59.","Total enrollment 100,585 (+6.8% YoY); Chamberlain returned to positive enrollment growth; Walden +12.3%.","Raised FY2026 guidance: revenue $1,930-1,945M (prev $1,900-1,940M); adjusted EPS $7.95-8.15 (prev $7.80-8.00).","Repurchased $66M shares in Q3; refinanced $510M Term Loan B due 2033; net leverage 0.7x.","Medical schools 97% first-time residency; AI certificates w/ Google Cloud enrolled 4,000+ learners."],"consensus_eps_estimate":null,"consensus_eps_actual":4.99,"consensus_revenue_estimate":null,"consensus_revenue_actual":1452703000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":98571,"accession_number":"0000730464-26-000015","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2026-04-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Covista targets 7-10% revenue CAGR, >120k enrollment by FY2029 in new strategy","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Financial targets through FY2029: revenue CAGR 7-10%, adjusted EPS CAGR 10-14%, enrollment >120,000.","Appointed Dr. Cheryl Holmes as Dean of Ross University School of Medicine (RUSM) effective March 2026.","Became founding member of Alliance for Advancing Rural Healthcare (AARH) to support federal Rural Health Transformation.","FY2026 guided revenue midpoint $1,920M and adjusted EPS midpoint $7.90; Q3 earnings call on May 7, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114139,"accession_number":"0000730464-26-000010","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"Covista enters $510M term loan refinancing, redeems $405M senior notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $510M 2026 Term Loans issued under amended credit agreement, maturing March 2, 2033.","Proceeds used to refinance existing term loans and redeem $404.95M of 5.50% Senior Secured Notes due 2028.","Interest rate: Term SOFR + 2.25% (0.75% floor) or alternate base rate + 1.25%, a 0.50% margin reduction.","Notes redemption completed on March 2, 2026; Indenture fully satisfied and discharged.","Amendment executed with Morgan Stanley Senior Funding as administrative agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114138,"accession_number":"0000730464-26-000007","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Covista unveils 'Purpose at Scale' 3-year plan; FY26 reaffirmed, ticker to CVSA","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Introduces 'Purpose at Scale' strategy for FY27-29 targeting revenue growth 6-11% and adj. EPS growth 9-16% annually.","Reaffirms FY26 guidance: revenue $1.9B-$1.94B (+6-8.5% YoY) and adj. EPS $7.80-$8.00 (+17-20% YoY).","Partners with GE Healthcare HelloAI for AI fluency and SAIC for rural healthcare workforce solutions.","Stock ticker changes to CVSA effective Feb 24, 2026 on NYSE; serves 97,000+ students vs 76,000 in June 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114137,"accession_number":"0001104659-26-011611","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2026-02-06T23:59:59+00:00","items":["5.03","7.01","9.01"],"status":"ready","headline":"Adtalem rebrands as Covista, ticker CVSA; launches research platform and investor day","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name changed from Adtalem Global Education to Covista Inc. effective Feb 5, 2026; NYSE ticker changes to CVSA effective Feb 24.","Largest U.S. healthcare educator: 97,000+ students, 385,000 alumni, 24,000 graduates/year (10% of nurses).","Released Covista Care Capacity Monitor (Gallup): 702,000 monthly healthcare job vacancies vs 306,000 unemployed workers.","Investor Day on Feb 24 to discuss long-term strategy; launches Covista Open Doors multi-year impact commitment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":114136,"accession_number":"0000730464-26-000003","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2026-01-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Adtalem reports Q2 FY2026 results; financial details not included in filing excerpt","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Company issued a press release on January 28, 2026, announcing second quarter fiscal 2026 academic, operating and financial results.","Exhibit 99.1 (press release) was referenced but not provided; no specific financial figures are available from this summary.","Investors should review the full press release for revenue, earnings, and guidance data."],"consensus_eps_estimate":null,"consensus_eps_actual":3.77,"consensus_revenue_estimate":null,"consensus_revenue_actual":965673000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130521,"accession_number":"0000730464-25-000063","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2025-12-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Adtalem completes $150M buyback, authorizes new $750M repurchase program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Completed $150M accelerated share repurchase program; repurchased 1.6M shares.","Board authorized new $750M share repurchase program through December 2028.","Since Feb 2022, returned $913M to shareholders: 17.2M shares at avg $52.94 (30% reduction in shares).","Debt reduced by $1.1B since Walden University acquisition (Aug 2021), to $508.4M as of Oct 31, 2025.","Outstanding shares as of Dec 10, 2025: 34.9M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130520,"accession_number":"0000730464-25-000060","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2025-11-14T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Adtalem shareholders elect 10 directors, ratify auditor, approve say-on-pay at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 10 director nominees elected with overwhelming support; votes for ranged from 30.9M to 31.7M.","Ratification of PricewaterhouseCoopers as auditor for FY2026 approved with 32.5M for, 627K against.","Advisory vote on executive compensation passed with 27.1M for, 4.3M against, 328K abstentions.","Broker non-votes on director election and say-on-pay were ~1.44M shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130519,"accession_number":"0000730464-25-000033","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Adtalem reports Q1 fiscal 2026 results; specific figures not available in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release issued on Oct 30, 2025 covering first quarter fiscal 2026 results.","No financial details (revenue, EPS, guidance) provided in the extracted filing text.","Filing under Item 2.02; press release furnished as Exhibit 99.1 but content not included.","Investors should refer to the full press release for quantitative results."],"consensus_eps_estimate":null,"consensus_eps_actual":1.67,"consensus_revenue_estimate":null,"consensus_revenue_actual":462288000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":130518,"accession_number":"0000730464-25-000029","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2025-10-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Dr. Karen Cox to retire as President of Chamberlain University, Adtalem's nursing school","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Karen Cox retiring after nearly 40-year healthcare career; led Chamberlain since 2018.","Chamberlain serves ~40,000 students online and across 24 campuses; largest nursing school in US.","Adtalem engaged Spencer Stuart for external search; Cox to transition once successor selected.","Cox previously served as president of American Academy of Nursing (2017-2019) and 30 years at Children's Mercy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147072,"accession_number":"0001558370-25-010778","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["1.01","2.02","2.03","9.01"],"status":"ready","headline":"Adtalem FY2025 revenue $1.79B (+12.9%), adj EPS $6.67 (+33%); FY2026 guidance $7.60-$7.90 adj EPS","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $457.1M (+11.5%), total enrollment 91,780 (+10.2% YoY).","FY2025 adj EPS $6.67 vs $5.01 prior year; adj EBITDA $459.7M (+21.8%).","FY2026 guidance: revenue $1,900-$1,940M, adj EPS $7.60-$7.90.","Increased revolver by $100M to $500M, maturity to Aug 2030, reduced pricing.","New $150M share repurchase authorization through May 2028."],"consensus_eps_estimate":null,"consensus_eps_actual":6.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":1788290000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.78,"calibrated_materiality_score":0.78,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":147071,"accession_number":"0001558370-25-009324","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2025-07-21T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"CEO Stephen Beard adopts 10b5-1 plan to sell up to 108,000 shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Chairman/CEO Beard entered 10b5-1 plan to sell up to 108,000 shares of common stock.","Sales require minimum price thresholds at a premium to current trading price as of June 10, 2025.","Estimated first sale date not before September 12, 2025; plan ends May 29, 2026.","Beard already exceeds company stock ownership guidelines; plan does not affect compliance.","Trades will be disclosed via Form 144 and Form 4 filings with SEC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165608,"accession_number":"0000730464-25-000007","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Adtalem Q3 FY2025 EPS $1.59 ($1.92 adj.), revenue $466.1M +12.9%; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $466.1M (+12.9% YoY); diluted EPS $1.59 (adj. $1.92, +28% YoY); net income $60.8M.","Total enrollment up 9.8% to 94,223; Chamberlain +6.8%, Walden +13.5%, Med/Vet +1.2%.","Completed $300M share repurchase program; new $150M authorization through May 2028.","FY2025 guidance raised: revenue $1,760-1,775M, adj. EPS $6.40-$6.60 (28-32% YoY growth).","Adjusted EBITDA $127.8M (+19.3% YoY); margin 27.4% vs 25.9% prior year."],"consensus_eps_estimate":1.609,"consensus_eps_actual":4.74,"consensus_revenue_estimate":null,"consensus_revenue_actual":1331184000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":165607,"accession_number":"0000730464-25-000005","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Adtalem authorizes $150M new buyback; completes $300M prior program, returns $763M since 2022","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorized $150M share repurchase program, expiring May 2028.","Prior $300M buyback program completed on May 5, 2025, ahead of original Jan 2027 expiry.","Since Feb 2022, $763M returned to shareholders; shares outstanding reduced by 28% at avg $49/share.","About 36M shares outstanding as of May 5, 2025.","Q3 FY2025 earnings call scheduled for May 8, 2025 after market close."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":183229,"accession_number":"0001558370-25-000543","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2025-01-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Adtalem Q2 FY2025 EPS $1.98 ($1.81 adjusted), revenue up 13.9%, guidance raised","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $447.7M (+13.9% YoY); GAAP net income $75.9M ($1.98 diluted EPS).","Adjusted EPS $1.81 (+47.2% YoY); adjusted EBITDA $125.0M (+35.1% YoY).","Total enrollment 91,264 (+11.6% YoY); Chamberlain +11.5%, Walden +13.2%.","FY2025 guidance raised: revenue $1,730M-$1,760M, adjusted EPS $6.10-$6.30.","Repurchased $38M shares in Q2; repaid $100M term loan B; net leverage 1.1x."],"consensus_eps_estimate":1.5632,"consensus_eps_actual":3.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":865129000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199811,"accession_number":"0001558370-24-015853","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2024-11-19T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Adtalem CEO Steve Beard elected Chairman; Q1 enrollment up 11.2% to 90,000+","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Steve Beard, President and CEO, unanimously elected Chairman of the Board effective Nov. 13, 2024.","Michael Malafronte transitions from Chairman to Lead Independent Director, Chair of Compensation Committee.","Q1 FY2025 total enrollment surpassed 90,000, up 11.2% YoY; ~90% enrolled in healthcare programs.","Annual meeting results: all 10 directors elected, PwC ratified as auditor, say-on-pay approved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":199810,"accession_number":"0001558370-24-013845","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2024-10-29T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Adtalem Q1 FY2025: Revenue up 13.2%, adj. EPS $1.29 (+38.7% YoY); raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $417.4M (+13.2% YoY); net income $46.2M vs $10.6M prior year; adj. EPS $1.29 vs $0.93.","Total enrollment 90,140, up 11.2% YoY; Chamberlain +11.7%, Walden +12.2%, Medical/Vet -0.7%.","FY2025 guidance raised: revenue $1,690M-$1,730M; adj. EPS $5.75-$5.95 (14.5%-18.5% growth).","Repurchased $34M of shares; $178M remaining under $300M buyback program through Jan 2027.","Repriced $253M Term Loan B, reducing interest rate by 75 bps; net leverage 1.0x."],"consensus_eps_estimate":null,"consensus_eps_actual":1.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":417400000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215831,"accession_number":"0001558370-24-012476","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2024-08-26T23:59:59+00:00","items":["8.01","2.03","9.01","1.01"],"status":"ready","headline":"Adtalem Global Education reprices term loans, reducing interest margin by 0.75%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amended Credit Agreement reduces interest rate margins by 0.75% and removes leverage-based pricing grid.","New interest rate: Term SOFR plus 2.75% or alternate base rate plus 1.75%, at company's option.","Amendment affects all outstanding term loans under the August 12, 2021 Credit Agreement.","Transaction closed August 21, 2024; administrative agent is Morgan Stanley Senior Funding, Inc."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":215830,"accession_number":"0001558370-24-011090","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2024-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Adtalem Q4 rev $409.9M (+12.4% YoY); FY25 EPS guidance $5.60-$5.85 above prior projections","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY24 diluted EPS $3.39; adjusted EPS $5.01 (+19% YoY). Revenue $1,584.7M (+9.2% YoY).","Total enrollment up 10.0% YoY to 83,321; Chamberlain +10.4%, Walden +11.3% for 6th and 4th straight quarters.","FY25 guidance: revenue $1,660M-$1,700M (5-7.5% growth); adjusted EPS $5.60-$5.85 (12-17% growth).","Repurchased $261M shares; repaid $50M Term Loan B, repriced remaining $253M at 50 bps lower rate; net leverage 1.2x.","Initiating Kansas City expansion with 24th Chamberlain location for ~550 students."],"consensus_eps_estimate":null,"consensus_eps_actual":3.39,"consensus_revenue_estimate":null,"consensus_revenue_actual":1584652000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235260,"accession_number":"0001558370-24-006546","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Adtalem Q3 revenue up 11.8% YoY; adjusted EPS $1.50, raises FY2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $412.7M (+11.8% YoY); total enrollment 85,809 (+7.8% YoY).","GAAP diluted EPS $0.93; adjusted EPS $1.50 (+32.7% YoY).","Adjusted EBITDA $107.1M (+24.6% YoY); margin 25.9% vs 23.3%.","FY2024 guidance raised: revenue $1,560-$1,580M, adjusted EPS $4.80-$5.00.","Chamberlain enrollment +9.0% (5th straight growth quarter); Walden enrollment +8.4%."],"consensus_eps_estimate":null,"consensus_eps_actual":2.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":1174745000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":235259,"accession_number":"0000730464-24-000004","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K/A","filed_at":"2024-04-12T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Adtalem finalizes separation agreement with ex-President Danaher; details severance terms","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Severance of $1,014,390 (1x salary + 70% MIP target) payable in 12 monthly installments.","FY23 MIP award set to 0% by CEO; no FY23 payout and no pro-rated FY24 MIP.","Unvested LTI awards (RSUs, PSUs, options) will continue to vest per award agreements.","One-time lump sum of $14,513 for COBRA subsidy for dependents; counsel fees of $62,000 paid.","Standard noncompete, nonsolicitation, confidentiality covenants apply."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253096,"accession_number":"0001157523-24-000163","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2024-02-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Adtalem counters Safkhet Capital short report, refutes claims on enrollment, graduation rates, and financials","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total enterprise enrollment up 6% YoY as of Dec 31, 2023; Chamberlain up 7%, Walden up 8%.","Chamberlain four-year graduation rate for all full-time students is 77% vs. national average of 49%.","Walden acquisition goodwill tested in May 2023; no impairment identified.","Company expects all degree programs to pass Department of Education gainful employment rule.","Calls Safkhet report a 'short and distort' scheme; denies material risk from borrower defense or 90/10 rule."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253095,"accession_number":"0001157523-24-000136","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2024-01-31T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Adtalem Q2 revenue +8.4% to $393.2M, raises FY guidance; short seller report disclosed","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $393.2M (+8.4% YoY); total enrollment 81,772 (+6.2%); Chamberlain enrollment +6.6%, Walden +7.9%.","Diluted EPS $0.98; adjusted EPS $1.23 (+5.1% YoY); adjusted EBITDA $92.6M (+2.2%); margin 23.5%.","FY2024 guidance raised: revenue $1,520-$1,560M (from $1,470-$1,530M); adj. EPS $4.55-$4.75 (from $4.25-$4.45).","Completed $300M buyback; new $300M authorization through Jan 2027; repaid $50M Term Loan B; repriced $253M at 50bps lower; net leverage 1.5x.","Filed risk factor re: short seller report published Jan 30 alleging misconduct; share price impacted; may lead to litigation/regulatory probes."],"consensus_eps_estimate":null,"consensus_eps_actual":1.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":762087000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253094,"accession_number":"0001157523-24-000084","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2024-01-19T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Adtalem authorizes $300M new share repurchase program through Jan 2027; completes prior $300M program","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["New $300M share buyback authorization expires Jan. 16, 2027; purchases may be open market or privately negotiated.","Prior $300M Feb 2022 program completed on Jan. 16, 2024, repurchasing 11.6M shares at avg $39.85.","Since Feb 2022, shares outstanding reduced by 23%; ~39.3M shares outstanding as of Jan. 16, 2024.","CEO Steve Beard cites confidence in growth strategy and robust cash flow supporting capital allocation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253093,"accession_number":"0001157523-24-000041","cik":730464,"company_name":"Covista Inc.","ticker":"CVSA","form_type":"8-K","filed_at":"2024-01-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Adtalem appoints Betty Vandenbosch to board, effective Jan 8, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Betty Vandenbosch appointed as independent director, will serve on Academic Quality Committee.","Vandenbosch brings 30 years of EdTech and academic leadership, including Coursera (SVP/Chief Content Officer) and Purdue Global chancellor.","Appointment effective January 8, 2024; compensation same as other non-employee directors per proxy filed Oct 2023.","Her background includes roles at Kaplan University (president 2015-2018) and Case Western University."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":4170144854.0397525,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}